Pharma News, 2021

In terms of approvals of new products, 2021 was the second-best year for cell and gene therapies and tissue products (The best year was 2016, when nine therapies were approved.). ...

FDA investigators observed numerous quality failures during an inspection of a KVK Tech generic drug manufacturing facility in Newton, Penn., ranging from lax cleaning to incomplete investigations ...

Scientists have detected 'brain tsunamis' in human beings that cause irreversible damage to the organ.

Just approved by the Food and Drug Administration, Vuity's new product has been found to take effect in as little as 15 minutes.

A phase 2 study of selinexor (Xopvio) for the treatment of myelofibrosis (MF) has been initiated and the first patient has been dosed with the agent, according to a press release by Karyopharm The...

A novel natural killer cell therapy is now on the fast track to FDA approval and being assessed in a phase 1 clinical trial.

There has been a remarkable increase in intake of simple sugar (sucrose, isomerized sugar (corn syrup)) from beverages and diets in modern society. 

Global pharmaceutical major Merck & Co., Inc. (NYSE:MRK) recently revealed that its investigational, orally administered antiviral medicine for treatment of COVID-19, molnupiravir, has been gra...

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants.

Faraday Pharmaceuticals, Inc., a muscle health-focused biopharmaceutical company developing therapeutics to treat patients experiencing potentially life changing critical illness, announced today t...

WHO officials remain cautious about claiming Omicron as a milder variant of the COVID-19 virus. 

The US Food and Drug Administration (FDA) has granted Fast Track designation to Eisai and Biogen’s experimental drug, lecanemab, to treat early Alzheimer’s disease (AD). ...